Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing vincristine administration errors: Does evidence support minibag infusions?

Lisa Schulmeister1

  • 1lisaschulmeister@hotmail.com

Clinical Journal of Oncology Nursing
|May 20, 2006
PubMed
Summary

Accidental intrathecal administration of vincristine sulfate, a medication for IV use only, leads to severe neurological damage and often death. This highlights critical medication safety concerns in clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Think This Can't Happen to You?

Clinical journal of oncology nursing·2025
Same author

Introduction.

Seminars in oncology nursing·2018
Same author

A Pathway to Publishing an Oncology Nursing Book.

Seminars in oncology nursing·2018
Same author

Publishing in Oncology Nursing: A Look to the Past, Present, and Future.

Seminars in oncology nursing·2018
Same author

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Oncology nursing forum·2017
Same author

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology.

Journal of oncology practice·2016

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Toxicology

Background:

  • Vincristine sulfate is indicated exclusively for intravenous (IV) administration.
  • Inadvertent intrathecal administration of vincristine sulfate poses a severe clinical risk.
  • Previous cases document devastating neurological consequences following accidental spinal administration.

Purpose of the Study:

  • To review the severe neurotoxicity associated with inadvertent intrathecal vincristine sulfate administration.
  • To emphasize the critical importance of medication safety protocols to prevent such errors.

Main Methods:

  • Review of existing medical literature and case reports on intrathecal vincristine sulfate administration.
  • Analysis of documented clinical outcomes and autopsy findings.

Related Experiment Videos

Main Results:

  • Intrathecal vincristine administration causes rapid sensory and motor dysfunction.
  • Neurological deterioration progresses to encephalopathy, coma, and frequently, death.
  • Autopsy reveals significant brain and spinal cord edema, congestion, axonal degeneration, and myelin loss.

Conclusions:

  • Accidental intrathecal vincristine sulfate administration is a fatal medication error.
  • Strict adherence to administration protocols is essential to prevent catastrophic patient harm.
  • Enhanced vigilance and system safeguards are crucial in healthcare settings.